4
Scholarly Works
50%
OA Ratio
0%
Collaborative Ratio
Scholar
Spyridi, Styliani
Department of Rehabilitation Sciences
0
H-index (Google Scholar)
-
Scholar Citations
Scholarly Works
Research Output
Recent Publications
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder
Publishing year: 2021
Journal article
Cochrane Database of Systematic Reviews, 2021, Volume 2021, Issue 9
Repository
Background: Many studies have recently been conducted to assess the antidepressant efficacy of glutamate modification in mood disorders. This is an update of a review first published in 2015 focusing on the use of glutamate receptor modulators in unipolar depression. Objectives: To assess the effects - and review the acceptability and tolerability - of ketamine and other glutamate receptor modulators in alleviating the acute symptoms of depression in people with unipolar major depressive disorder. Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), Ovid MEDLINE, Embase and PsycINFO all years to July 2020. We did not apply any restrictions to date, language or publication status. Selection criteria: Double- or single-blinded randomised controlled trials (RCTs) comparing ketamine, memantine, esketamine or other glutamate receptor modulators with placebo (pill or saline infusion), other active psychotropic drugs, or electroconvulsive therapy (ECT) in adults with unipolar major depression. Data collection and analysis: Three review authors independently identified studies, assessed trial quality and extracted data. The primary outcomes were response rate (50% reduction on a standardised rating scale) and adverse events. We decided a priori to measure the efficacy outcomes at different time points and run sensitivity/subgroup analyses. Risk of bias was assessed using the Cochrane tool, and certainty of the evidence was assessed using GRADE. Ma...
Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
Publishing year: 2021
Journal article
Cochrane Database of Systematic Reviews, 2021, Volume 2021, Issue 10
Repository
Background: Glutamergic system dysfunction has been implicated in the pathophysiology of bipolar depression. This is an update of the 2015 Cochrane Review for the use of glutamate receptor modulators for depression in bipolar disorder. Objectives: 1. To assess the effects of ketamine and other glutamate receptor modulators in alleviating the acute symptoms of depression in people with bipolar disorder.
2. To review the acceptability of ketamine and other glutamate receptor modulators in people with bipolar disorder who are experiencing depressive symptoms. Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), Ovid MEDLINE, Embase and PsycINFO all years to July 2020. We did not apply any restrictions to date, language or publication status. Selection criteria: RCTs comparing ketamine or other glutamate receptor modulators with other active psychotropic drugs or saline placebo in adults with bipolar depression. Data collection and analysis: Two review authors independently selected studies for inclusion, assessed trial quality and extracted data. Primary outcomes were response rate and adverse events. Secondary outcomes included remission rate, depression severity change scores, suicidality, cognition, quality of life, and dropout rate. The GRADE framework was used to assess the certainty of the evidence. Main results: Ten studies (647 participants) were included in this review (an additional five studies compared to the 2015 review). There w...
Benzodiazepines for psychosis-induced aggression or agitation
Publishing year: 2018
Journal article
Schizophrenia Bulletin, 2018, Volume 44, Issue 5
Repository
Pages 966-969
Acute psychotic illness, especially when associated with
agitated or violent behavior, can require urgent pharmacological tranquillization or sedation. In many countries,
benzodiazepines (either alone or in combination with
antipsychotics) are often used in this situation (1).
Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation)
Publishing year: 2018
Journal article
Cochrane Database of Systematic Reviews, 2018, Volume 2018, Issue 1
Repository
Background: People experiencing psychosis may become aggressive. Antipsychotics, such as aripiprazole in intramuscular form, can be used in such situations. Objectives: To evaluate the effects of intramuscular aripiprazole in the treatment of psychosis-induced aggression or agitation (rapid tranquillisation). Search methods: On 11 December 2014 and 11 April 2017, we searched the Cochrane Schizophrenia Group’s Study-based Register of Trials which is based on regular searches of CINAHL, BIOSIS, AMED, Embase, PubMed, MEDLINE, PsycINFO, and registries of clinical trials. Selection criteria: All randomised controlled trials (RCTs) that randomised people with psychosis-induced aggression or agitation to receive either intramuscular aripiprazole or another intramuscular intervention. Data collection and analysis: We independently inspected citations and, where possible, abstracts, ordered papers and re-inspected and quality assessed these. We included studies that met our selection criteria. At least two review authors independently extracted data from the included studies. We chose a fixed-effect model. We analysed dichotomous data using risk ratio (RR) and the 95% confidence intervals (CI). We analysed continuous data using mean differences (MD) and their CIs. We assessed risk of bias for included studies and used GRADE to create 'Summary of findings' tables. Main results: Searching found 63 records referring to 21 possible trials. We could only include three studies, all complete...
4
Unique publications
50%
Open access (2 publications; 2 without information)
0%
With other institutions (0 publications; 4 without information)
H-Index Reports
| Index type | Scopus | Google Scholar | Web of Science |
|---|---|---|---|
| H-index | 0 | 0 | 0 |
| H5-index | 0 | 0 | 0 |
| H10-index | 0 | 0 | 0 |
Publications per year and source
No description yet.
- Faculty
- Faculty of Health Sciences
- Department
- Department of Rehabilitation Sciences
